239 related articles for article (PubMed ID: 33281543)
1. Neurodegenerative Disorders of the Eye and of the Brain: A Perspective on Their Fluid-Dynamical Connections and the Potential of Mechanism-Driven Modeling.
Guidoboni G; Sacco R; Szopos M; Sala L; Verticchio Vercellin AC; Siesky B; Harris A
Front Neurosci; 2020; 14():566428. PubMed ID: 33281543
[TBL] [Abstract][Full Text] [Related]
2. [New concepts of pathogenesis, diagnosis, and treatment of neurodegenerative diseases].
Ugriumov MV
Vestn Ross Akad Med Nauk; 2010; (8):6-19. PubMed ID: 20919532
[TBL] [Abstract][Full Text] [Related]
3. Role of oxidative stress and antioxidants in neurodegenerative diseases.
Rao AV; Balachandran B
Nutr Neurosci; 2002 Oct; 5(5):291-309. PubMed ID: 12385592
[TBL] [Abstract][Full Text] [Related]
4. [Biomarkers for dementia and other neurodegenerative diseases : Current developments].
Wiltfang J; Lewczuk P; Otto M
Nervenarzt; 2016 Dec; 87(12):1305-1309. PubMed ID: 27844089
[TBL] [Abstract][Full Text] [Related]
5. Urinary Biomarkers for Neurodegenerative Diseases.
Seol W; Kim H; Son I
Exp Neurobiol; 2020 Oct; 29(5):325-333. PubMed ID: 33154195
[TBL] [Abstract][Full Text] [Related]
6. The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.
Baldacci F; Mazzucchi S; Della Vecchia A; Giampietri L; Giannini N; Koronyo-Hamaoui M; Ceravolo R; Siciliano G; Bonuccelli U; Elahi FM; Vergallo A; Lista S; Giorgi FS; Hampel H
Expert Rev Mol Diagn; 2020 Apr; 20(4):421-441. PubMed ID: 32066283
[No Abstract] [Full Text] [Related]
7. Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery.
Wang X; Zhang JB; He KJ; Wang F; Liu CF
Front Pharmacol; 2021; 12():713963. PubMed ID: 34335276
[TBL] [Abstract][Full Text] [Related]
8. Oculomics: A Crusade Against the Four Horsemen of Chronic Disease.
Patterson EJ; Bounds AD; Wagner SK; Kadri-Langford R; Taylor R; Daly D
Ophthalmol Ther; 2024 Jun; 13(6):1427-1451. PubMed ID: 38630354
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going?
Lewczuk P; Kornhuber J
Expert Rev Proteomics; 2011 Aug; 8(4):447-58. PubMed ID: 21819301
[TBL] [Abstract][Full Text] [Related]
10. Head Position During Sleep: Potential Implications for Patients with Neurodegenerative Disease.
Levendowski DJ; Gamaldo C; St Louis EK; Ferini-Strambi L; Hamilton JM; Salat D; Westbrook PR; Berka C
J Alzheimers Dis; 2019; 67(2):631-638. PubMed ID: 30614805
[TBL] [Abstract][Full Text] [Related]
11. Disease modification and Neuroprotection in neurodegenerative disorders.
Cummings J
Transl Neurodegener; 2017; 6():25. PubMed ID: 29021896
[TBL] [Abstract][Full Text] [Related]
12. The Eye As a Biomarker for Alzheimer's Disease.
Lim JK; Li QX; He Z; Vingrys AJ; Wong VH; Currier N; Mullen J; Bui BV; Nguyen CT
Front Neurosci; 2016; 10():536. PubMed ID: 27909396
[TBL] [Abstract][Full Text] [Related]
13. Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.
Mollenhauer B; Parnetti L; Rektorova I; Kramberger MG; Pikkarainen M; Schulz-Schaeffer WJ; Aarsland D; Svenningsson P; Farotti L; Verbeek MM; Schlossmacher MG
J Neurochem; 2016 Oct; 139 Suppl 1():290-317. PubMed ID: 26452984
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective.
Lewczuk P; Mroczko B; Fagan A; Kornhuber J
Adv Med Sci; 2015 Mar; 60(1):76-82. PubMed ID: 25579841
[TBL] [Abstract][Full Text] [Related]
15. Is primary open-angle glaucoma an ocular manifestation of systemic disease?
Wey S; Amanullah S; Spaeth GL; Ustaoglu M; Rahmatnejad K; Katz LJ
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):665-673. PubMed ID: 30643967
[TBL] [Abstract][Full Text] [Related]
16. Fast circulation of cerebrospinal fluid: an alternative perspective on the protective role of high intracranial pressure in ocular hypertension.
Wostyn P; De Groot V; Van Dam D; Audenaert K; Killer HE; De Deyn PP
Clin Exp Optom; 2016 May; 99(3):213-8. PubMed ID: 26691953
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.
Baldacci F; Lista S; Cavedo E; Bonuccelli U; Hampel H
Expert Rev Proteomics; 2017 Apr; 14(4):285-299. PubMed ID: 28281838
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
Skillbäck T; Farahmand BY; Rosén C; Mattsson N; Nägga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
Brain; 2015 Sep; 138(Pt 9):2716-31. PubMed ID: 26133663
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status.
Koníčková D; Menšíková K; Tučková L; Hényková E; Strnad M; Friedecký D; Stejskal D; Matěj R; Kaňovský P
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885064
[TBL] [Abstract][Full Text] [Related]
20. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.
Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN
Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
